Premium
Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G 1 ‐modulated P53 activity
Author(s) -
Wang Saifeng,
Qiu Lipeng,
Yan Xiaoli,
Jin Wensong,
Wang Yanzhong,
Chen Lizhao,
Wu Erjie,
Ye Xin,
Gao George F.,
Wang Fusheng,
Chen Yu,
Duan Zhongping,
Meng Songdong
Publication year - 2012
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.24809
Subject(s) - mir 122 , hepatitis b virus , cyclin a , biology , viral replication , transfection , hbx , gene knockdown , cyclin e1 , cyclin a2 , virology , microbiology and biotechnology , microrna , cancer research , cyclin , cell cycle , virus , cell culture , hepatitis c virus , cell , gene , biochemistry , genetics
Hepatitis B virus (HBV) causes chronic infection in about 350 million people worldwide. Given the important role of the most abundant liver‐specific microRNA, miR‐122, in hepatic function and liver pathology, here we investigated the potential role and mechanism of miR‐122 in regulating HBV replication. We found that miR‐122 expression in liver was significantly down‐regulated in patients with HBV infection compared with healthy controls, and the miR‐122 levels were negatively correlated with intrahepatic viral load and hepatic necroinflammation. The depletion of endogenous miR‐122 by its antisense inhibitor led to enhanced HBV replication, whereas overexpression of miR‐122 by transfection of mimic or its expression vector inhibited viral production. We next identified cyclin G 1 as an miR‐122 target from multiple candidate target genes that are involved in the regulation of HBV replication. Overexpression and knockdown studies both showed that cyclin G 1 regulated viral replication in HBV transfected cells. We also observed that cyclin G 1 expression was up‐regulated in HBV‐infected patients, and cyclin G 1 levels were inversely associated with miR‐122 expression in liver tissues. Using coimmunoprecipitation, a luciferase reporter system, and electrophoretic mobility shift assay, we further demonstrated that cyclin G 1 specifically interacted with p53, and this interaction blocked the specific binding of p53 to HBV enhancer elements and simultaneously abrogated p53‐mediated inhibition of HBV transcription. Finally, we show that miR‐122 suppressed HBV replication in p53 wildtype cells but not in null isogenic cells. Conclusion: miR‐122 down‐regulates its target cyclin G 1 , and thus interrupts the interaction between cyclin G 1 and p53 and abrogates p53‐mediated inhibition of HBV replication. Our work shows that miR‐122 down‐regulation induced by HBV infection can impact HBV replication and possibly contribute to viral persistence and carcinogenesis. (H EPATOLOGY 2012;)